Pharma Logistics: From Visibility to Predictive Decisions
Predictive pharmaceutical logistics promises earlier intervention, but practical results depend on data quality, operating procedures and accountable decisions.
For a temperature-sensitive pharmaceutical shipment, learning that something went wrong is useful. Learning that something is likely to go wrong—and intervening before product integrity is threatened—is considerably more valuable.
That difference is central to the industry’s discussion about the direction of pharmaceutical logistics. In an October 19 article for pharmaphorum, Envirotainer executive Niklas Adamsson argues that logistics organizations should use shipment and historical performance data to anticipate risk rather than relying on retrospective monitoring.
The broader issue applies well beyond healthcare. Visibility has become a foundational logistics capability. The next competitive question is whether organizations can turn that visibility into timely, defensible decisions.
Cold-chain logistics combines transportation variability with unusually high consequences for failure. Delays, unexpected dwell time, equipment problems, or excursions outside a validated temperature range can trigger investigations and potentially compromise product usability.
This story was originally published by Logistics Viewpoints. Read the full story at Logistics Viewpoints →
Conversation